Ashok Seshadri

779 total citations · 1 hit paper
18 papers, 467 citations indexed

About

Ashok Seshadri is a scholar working on Pharmacology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Ashok Seshadri has authored 18 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Clinical Psychology and 5 papers in Psychiatry and Mental health. Recurrent topics in Ashok Seshadri's work include Treatment of Major Depression (6 papers), Tryptophan and brain disorders (3 papers) and Personality Disorders and Psychopathology (3 papers). Ashok Seshadri is often cited by papers focused on Treatment of Major Depression (6 papers), Tryptophan and brain disorders (3 papers) and Personality Disorders and Psychopathology (3 papers). Ashok Seshadri collaborates with scholars based in United States, Australia and India. Ashok Seshadri's co-authors include Balwinder Singh, Larry J. Prokop, Mark A. Frye, Mohammed Yousufuddin, Gaston Baslet, Lorna Myers, Sidra Saleem, Karan Patel, Zhen Wang and Kogulavadanan Arumaithurai and has published in prestigious journals such as Journal of Affective Disorders, Mayo Clinic Proceedings and Journal of the Neurological Sciences.

In The Last Decade

Ashok Seshadri

16 papers receiving 449 citations

Hit Papers

Augmentation strategies for treatment resistant major dep... 2022 2026 2023 2024 2022 40 80 120

Peers

Ashok Seshadri
Ashok Seshadri
Citations per year, relative to Ashok Seshadri Ashok Seshadri (= 1×) peers Alexander Brunnauer

Countries citing papers authored by Ashok Seshadri

Since Specialization
Citations

This map shows the geographic impact of Ashok Seshadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Seshadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Seshadri more than expected).

Fields of papers citing papers by Ashok Seshadri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Seshadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Seshadri. The network helps show where Ashok Seshadri may publish in the future.

Co-authorship network of co-authors of Ashok Seshadri

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok Seshadri. A scholar is included among the top collaborators of Ashok Seshadri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok Seshadri. Ashok Seshadri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pahwa, Mehak, Nicolás A. Núñez, Boney Joseph, et al.. (2025). Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis. Psychopharmacology Bulletin. 50(4). 118–136. 1 indexed citations
2.
Núñez, Nicolás A., Boney Joseph, Mehak Pahwa, et al.. (2025). An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis. Psychopharmacology Bulletin. 50(4). 137–163.
3.
Kumar, Rakesh, Nicolás A. Núñez, Boney Joseph, et al.. (2024). Metabolomic biomarkers for (R, S)‐ketamine and (S)‐ketamine in treatment‐resistant depression and healthy controls: A systematic review. Bipolar Disorders. 26(4). 321–330. 6 indexed citations
4.
Seshadri, Ashok, Larry J. Prokop, & Balwinder Singh. (2024). Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. Journal of Affective Disorders. 356. 379–384. 12 indexed citations
5.
Núñez, Nicolás A., et al.. (2023). Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review. Brain Sciences. 13(4). 547–547.
6.
Kumar, Rakesh, Marius N. Stan, Ashok Seshadri, et al.. (2023). The Association Between Thyroid Stimulating Hormone and Depression. Mayo Clinic Proceedings. 98(7). 1009–1020. 15 indexed citations
7.
Núñez, Nicolás A., Boney Joseph, Mehak Pahwa, et al.. (2022). Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. Journal of Affective Disorders. 302. 385–400. 122 indexed citations breakdown →
8.
Seshadri, Ashok, Vishnu Sundaresh, Larry J. Prokop, & Balwinder Singh. (2022). Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review. Brain Sciences. 12(11). 1540–1540. 12 indexed citations
9.
Seshadri, Ashok, et al.. (2021). Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder. The Primary Care Companion For CNS Disorders. 23(4). 16 indexed citations
10.
Yousufuddin, Mohammed, James P. Moriarty, Kandace A. Lackore, et al.. (2020). Initial and subsequent 3-year cost after hospitalization for first acute ischemic stroke and intracerebral hemorrhage. Journal of the Neurological Sciences. 419. 117181–117181. 8 indexed citations
11.
Seshadri, Ashok, Balwinder Singh, Matthew M. Clark, et al.. (2020). Exercise, Yoga, and Tai Chi for Treatment of Major Depressive Disorder in Outpatient Settings. The Primary Care Companion For CNS Disorders. 23(1). 21 indexed citations
12.
Seshadri, Ashok, Matthew M. Clark, Simon Kung, et al.. (2020). Feasibility Study of Stress Management and Resiliency Training (SMART) in Patients With Major Depressive Disorder. The Primary Care Companion For CNS Disorders. 22(3). 6 indexed citations
13.
Seshadri, Ashok, Balwinder Singh, Matthew M. Clark, et al.. (2020). Mindfulness-Based Cognitive Therapy, Acceptance and Commitment Therapy, and Positive Psychotherapy for Major Depression. American Journal of Psychotherapy. 74(1). 4–12. 15 indexed citations
14.
Pahwa, Mehak, Nicolás A. Núñez, Boney Joseph, et al.. (2020). Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis.. PubMed. 50(4). 118–136. 3 indexed citations
15.
Patel, Urvish, Arsalan Anwar, Sidra Saleem, et al.. (2019). Artificial intelligence as an emerging technology in the current care of neurological disorders. Journal of Neurology. 268(5). 1623–1642. 118 indexed citations
16.
Yousufuddin, Mohammed, Paul Y. Takahashi, Brittny Major, et al.. (2019). Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis. BMJ Open. 9(12). e028638–e028638. 29 indexed citations
17.
Angstman, Kurt B., et al.. (2017). Personality Disorders in Primary Care: Impact on Depression Outcomes Within Collaborative Care. Journal of Primary Care & Community Health. 8(4). 233–238. 21 indexed citations
18.
Baslet, Gaston, Ashok Seshadri, Adriana Bermeo‐Ovalle, Kim Willment, & Lorna Myers. (2015). Psychogenic Non-epileptic Seizures: An Updated Primer. Psychosomatics. 57(1). 1–17. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026